Clinical trial
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger)…
NCT00077584 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00077584 |
|---|---|
| Title | Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma |
| Official title | A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Effect of Bosentan on Healing and Prevention of Ischemic Digital Ulcers in Patients With Systemic Sclerosis |
| Acronym | RAPIDS-2 |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Digital Ulcers, Systemic Sclerosis |
| Intervention type | Drug |
| Interventions | Bosentan 62.5 mg, Bosentan 125 mg, Placebo |
| Enrollment | 188 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Feb 11, 2004 |
| Last update posted | Feb 3, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: